Adage Capital Partners Gp, L.L.C. Legend Biotech Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$416 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$279 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$247 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$213 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$188 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.23B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...